National Glucose-Lowering Treatment Complexity Is Greater in Nursing Home Residents than Community-Dwelling Adults-Reference-Cited by-同舟云学术

National Glucose-Lowering Treatment Complexity Is Greater in Nursing Home Residents than Community-Dwelling Adults

Published:2016-09-27 Issue:11 Volume:64 Page:e233-e235
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Zullo Andrew R.¹^ORCID,Dore David D.¹²,Gutman Roee³,Mor Vincent¹,Smith Robert J.¹⁴

Affiliation:

1. Department of Health Services, Policy, and Practice; School of Public Health; Brown University; Providence Rhode Island

2. Optum Epidemiology; Boston Massachusetts

3. Department of Biostatistics; School of Public Health; Brown University; Providence Rhode Island

4. Department of Medicine; Alpert Medical School; Brown University; Providence Rhode Island

Funder

Agency for Healthcare Research and Quality

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.14485/fullpdf

Reference10 articles.

1. Management of diabetes in long-term care and skilled nursing facilities: A position statement of the American Diabetes Association;Munshi;Diabetes Care,2016

2. Briesacher B Doshi J Stuart B Medication use in long-term care facilities and community settings for Medicare beneficiaries with cardiovascular disease http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf

3. Diabetes in older adults: A consensus report;Kirkman;J Am Geriatr Soc,2012

4. The residential history file: Studying nursing home residents' long-term care histories(*);Intrator;Health Serv Res,2011

5. A comprehensive clinical assessment tool to inform policy and practice: Applications of the Minimum Data Set;Mor;Med Care,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety and cardiovascular effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in nursing homes;Diabetes, Obesity and Metabolism;2024-05-23

2. Adoption of sodium‐glucose cotransporter‐2 inhibitors among prescribers caring for nursing home residents;Journal of the American Geriatrics Society;2023-04-20

3. Comparative safety of sulfonylureas among U.S. nursing home residents;Journal of the American Geriatrics Society;2022-12-10

4. Electronic Health Records to Rapidly Assess Biosimilar Uptake: An Example Using Insulin Glargine in a Large U.S. Nursing Home Cohort;Frontiers in Pharmacology;2022-05-04

5. Effects of dipeptidyl peptidase‐4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents;Diabetes, Obesity and Metabolism;2021-10-27